Dell Faulkingham Akebia Therapeutics, Inc. (AKBA) insider trading activity

AKBA Quotes by TradingView

Dell Faulkingham is SVP, CCO of Akebia Therapeutics, Inc.. Currently has a direct ownership of 173,841 shares of AKBA, which is worth approximately $318,129. The most recent transaction as insider was on Mar 01, 2022, when has been sold 6,705 shares (Common Stock) at a price of $2.17 per share, resulting in proceeds of $14,550. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 174K
0% 3M change
0% 12M change
Total Value Held $318,129

Dell Faulkingham Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 01 2022
SELL
Open market or private sale
$14,550 $2.17 p/Share
6,705 Reduced 3.71%
173,841 Common Stock
Feb 28 2022
SELL
Open market or private sale
$13,930 $2.15 p/Share
6,479 Reduced 4.73%
130,546 Common Stock
Feb 28 2022
BUY
Grant, award, or other acquisition
-
50,000 Added 21.69%
180,546 Common Stock
Apr 01 2021
SELL
Open market or private sale
$3,237 $3.4 p/Share
952 Reduced 0.69%
137,025 Common Stock
Mar 16 2021
BUY
Grant, award, or other acquisition
-
9,152 Added 6.22%
137,977 Common Stock
Mar 01 2021
SELL
Open market or private sale
$22,947 $3.4 p/Share
6,749 Reduced 4.98%
128,825 Common Stock
Feb 26 2021
BUY
Grant, award, or other acquisition
-
62,000 Added 31.38%
135,574 Common Stock
DF

Dell Faulkingham

SVP, CCO
Cambridge, MA

Track Institutional and Insider Activities on AKBA

Follow Akebia Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AKBA shares.

Notify only if

Insider Trading

Get notified when an Akebia Therapeutics, Inc. insider buys or sells AKBA shares.

Notify only if

News

Receive news related to Akebia Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AKBA